April has a history of being a strong month, though it's not a guarantee. Here's a pharmaceutical stock that should benefit no matter how the month turns out. More
-
Sponsored By:
-
Sponsored By:
-
Sponsored By:
LLY
Trade of the Day: Eli Lilly (LLY)
This major pharmaceutical company has been in an uptrend along with many other drug stocks. More
The Best and Worst Mutual Funds of Q1 2013
Healthcare and Japanese stocks were among some of the hottest mutual fund flavors of the year's first quarter, while India and gold lagged behind. More
3 Kinds of Stock to Make Hay While the Sun Shines
As we've learned, it doesn't take a strong economy to make a strong market. I recommend taking advantage of three particular types of stocks as long as the market continues to be strong. More
4 Call Option Contenders: Pharmaceuticals
These pharmaceutical stocks are trading near their support levels, but have a good chance of making a spike up. Take advantage with call options. More
Should I Buy Merck? 3 Pros, 3 Cons
Merck is in the midst of a prolonged downtrend after hitting multiyear highs in 2012. Should you get in, or keep avoiding the Big Pharma stock? More
Winners After Novo Nordisk’s Insulin Rejection
Eli Lilly and Sanofi look like the biggest players that are best suited to benefit from Novo Nordisk's diabetes-drug setback, but a smaller player could emerge, too. More
